Monopar Therapeutics Inc. (MNPR) Free cash flow
Monopar Therapeutics Inc. (MNPR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to MNPRSource: SEC XBRL filings · For reference only · Not investment advice
More MNPR financial trends
MNPR RevenueMNPR Net incomeMNPR Net marginMNPR Gross profitMNPR Gross marginMNPR Operating incomeMNPR Operating marginMNPR Operating cash flowMNPR Capital expendituresMNPR Return on equityMNPR Stock buybacksMNPR Dividends paidMNPR Total assetsMNPR Total liabilitiesMNPR Shareholders’ equityMNPR overview →